Share Price and Basic Stock Data
Last Updated: November 26, 2025, 6:27 pm
| PEG Ratio | 3.04 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Vishnu Chemicals Ltd operates in the inorganic chemicals sector, specializing in a variety of products. The company reported a sales figure of ₹1,391 Cr for the fiscal year ending March 2023, marking a significant increase from ₹1,069 Cr in March 2022. This upward trend continued into the trailing twelve months (TTM), where sales stood at ₹1,512 Cr. However, a decline was noted in the fiscal year 2024, with revenues dropping to ₹1,213 Cr before rebounding to ₹1,447 Cr in March 2025. Quarterly revenue trends indicate fluctuations; for instance, the June 2023 sales were ₹301 Cr, which slightly improved to ₹308 Cr in September 2023. The company’s sales growth trajectory reflects both market demand and operational adjustments in a competitive landscape, where it must navigate price volatility and supply chain challenges common in the chemicals industry.
Profitability and Efficiency Metrics
Vishnu Chemicals recorded a robust operating profit margin (OPM) of 16% for the fiscal year 2025, which aligns with its historical performance of 17% in the previous year. The company’s net profit for the same period was ₹127 Cr, compared to ₹101 Cr in March 2024, highlighting a commendable growth rate. The interest coverage ratio (ICR) stood at 6.53x, indicating a strong ability to meet interest obligations, while return on equity (ROE) was reported at 15.5%, signaling effective utilization of shareholders’ funds. Efficiency metrics such as the cash conversion cycle (CCC) were reported at 145 days, suggesting a need for operational improvements in inventory and receivables management. Overall, while profitability remains solid, the company must address efficiency challenges to enhance cash flows and strengthen its financial standing in the sector.
Balance Sheet Strength and Financial Ratios
The balance sheet of Vishnu Chemicals exhibits a stable structure, characterized by a total debt to equity ratio of 0.36, reflecting prudent leverage levels. The company reported no borrowings, which positions it favorably in terms of financial health. The price to book value (P/BV) ratio stood at 3.32x, indicating a premium valuation relative to its book value of ₹137.67 per share as of March 2025. The current ratio was reported at 1.70, suggesting adequate liquidity to cover short-term obligations. Furthermore, the return on capital employed (ROCE) was at 18.1%, showcasing effective capital utilization. These metrics collectively indicate a solid financial foundation, but the company must remain vigilant against potential market fluctuations that could impact its capital efficiency and liquidity.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Vishnu Chemicals reflects a strong promoter presence, holding 69.21% as of March 2025. This stability among promoters can be seen as a positive sign for investor confidence. Foreign institutional investors (FIIs) increased their stake to 2.23%, while domestic institutional investors (DIIs) held 5.59% of the shares. The public shareholding stood at 22.97%, with a total of 31,754 shareholders, indicating growing retail interest. However, there has been a slight decline in promoter holdings from 75% in early 2023 to the current level, which could raise questions about long-term commitment. Overall, the diverse shareholding structure, combined with a solid promoter base, suggests a balanced approach to governance and investor relations.
Outlook, Risks, and Final Insight
Vishnu Chemicals is poised for growth, with a strong sales rebound anticipated in the coming fiscal year. However, it faces risks such as fluctuating raw material prices and potential regulatory changes affecting the chemicals industry. The company’s ability to maintain operational efficiency will be crucial in mitigating these risks. Furthermore, while profitability metrics are encouraging, ongoing scrutiny of cash flows and working capital management will be essential to sustain growth. Should the company successfully navigate these challenges, it could enhance its competitive position and market share. Conversely, failure to adapt to market dynamics could hinder its performance, necessitating strategic adjustments to ensure resilience in a volatile environment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Vishnu Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 3,015 Cr. | 46.5 | 125/40.8 | 150 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 16.1 Cr. | 32.1 | 48.3/25.8 | 69.8 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 203 Cr. | 259 | 410/238 | 12.1 | 211 | 3.08 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 6,417 Cr. | 520 | 730/408 | 31.3 | 157 | 0.58 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 333 Cr. | 426 | 536/376 | 16.2 | 144 | 0.70 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 4,847.00 Cr | 608.24 | 197.50 | 160.00 | 0.50% | 13.95% | 10.65% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 359 | 371 | 325 | 336 | 301 | 308 | 304 | 300 | 339 | 344 | 371 | 393 | 347 |
| Expenses | 301 | 312 | 273 | 275 | 250 | 262 | 263 | 237 | 283 | 299 | 308 | 329 | 291 |
| Operating Profit | 58 | 59 | 52 | 61 | 51 | 46 | 41 | 64 | 56 | 45 | 64 | 64 | 56 |
| OPM % | 16% | 16% | 16% | 18% | 17% | 15% | 13% | 21% | 16% | 13% | 17% | 16% | 16% |
| Other Income | 2 | 4 | 6 | 3 | 2 | 3 | 4 | 3 | 3 | 4 | 3 | 6 | 5 |
| Interest | 7 | 8 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 8 | 8 |
| Depreciation | 7 | 7 | 7 | 7 | 7 | 9 | 9 | 9 | 9 | 9 | 12 | 8 | 10 |
| Profit before tax | 47 | 48 | 42 | 49 | 37 | 31 | 27 | 49 | 40 | 30 | 44 | 53 | 42 |
| Tax % | 27% | 27% | 25% | 27% | 23% | 22% | 23% | 43% | 24% | 25% | 23% | 27% | 23% |
| Net Profit | 34 | 35 | 32 | 36 | 29 | 24 | 21 | 28 | 30 | 23 | 34 | 39 | 32 |
| EPS in Rs | 5.71 | 5.88 | 5.32 | 5.97 | 4.79 | 3.66 | 3.17 | 4.23 | 4.65 | 3.49 | 5.25 | 5.78 | 4.79 |
Last Updated: August 20, 2025, 1:20 am
Below is a detailed analysis of the quarterly data for Vishnu Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 347.00 Cr.. The value appears to be declining and may need further review. It has decreased from 393.00 Cr. (Mar 2025) to 347.00 Cr., marking a decrease of 46.00 Cr..
- For Expenses, as of Jun 2025, the value is 291.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 329.00 Cr. (Mar 2025) to 291.00 Cr., marking a decrease of 38.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 56.00 Cr.. The value appears to be declining and may need further review. It has decreased from 64.00 Cr. (Mar 2025) to 56.00 Cr., marking a decrease of 8.00 Cr..
- For OPM %, as of Jun 2025, the value is 16.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00%.
- For Other Income, as of Jun 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2025) to 5.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For Depreciation, as of Jun 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 42.00 Cr.. The value appears to be declining and may need further review. It has decreased from 53.00 Cr. (Mar 2025) to 42.00 Cr., marking a decrease of 11.00 Cr..
- For Tax %, as of Jun 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 23.00%, marking a decrease of 4.00%.
- For Net Profit, as of Jun 2025, the value is 32.00 Cr.. The value appears to be declining and may need further review. It has decreased from 39.00 Cr. (Mar 2025) to 32.00 Cr., marking a decrease of 7.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 4.79. The value appears to be declining and may need further review. It has decreased from 5.78 (Mar 2025) to 4.79, marking a decrease of 0.99.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:10 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 418 | 480 | 507 | 643 | 769 | 674 | 679 | 1,069 | 1,391 | 1,213 | 1,447 | 1,512 |
| Expenses | 339 | 396 | 441 | 562 | 667 | 591 | 600 | 911 | 1,160 | 1,010 | 1,217 | 1,270 |
| Operating Profit | 79 | 84 | 66 | 81 | 102 | 82 | 79 | 158 | 231 | 202 | 229 | 241 |
| OPM % | 19% | 18% | 13% | 13% | 13% | 12% | 12% | 15% | 17% | 17% | 16% | 16% |
| Other Income | 1 | 2 | 7 | 8 | 3 | 7 | 3 | 6 | 15 | 12 | 15 | 23 |
| Interest | 34 | 37 | 44 | 49 | 47 | 39 | 27 | 28 | 35 | 37 | 38 | 39 |
| Depreciation | 12 | 13 | 16 | 19 | 21 | 20 | 20 | 23 | 26 | 34 | 38 | 40 |
| Profit before tax | 34 | 36 | 14 | 22 | 37 | 30 | 34 | 112 | 185 | 144 | 168 | 185 |
| Tax % | 36% | 41% | 52% | 35% | 35% | 27% | -1% | 28% | 26% | 30% | 25% | |
| Net Profit | 22 | 21 | 7 | 14 | 24 | 22 | 34 | 81 | 137 | 101 | 127 | 138 |
| EPS in Rs | 3.66 | 3.56 | 1.10 | 2.42 | 4.08 | 3.72 | 5.78 | 13.63 | 22.86 | 15.43 | 18.81 | 20.70 |
| Dividend Payout % | 11% | 6% | 0% | 8% | 5% | 5% | 3% | 3% | 2% | 2% | 2% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -4.55% | -66.67% | 100.00% | 71.43% | -8.33% | 54.55% | 138.24% | 69.14% | -26.28% | 25.74% |
| Change in YoY Net Profit Growth (%) | 0.00% | -62.12% | 166.67% | -28.57% | -79.76% | 62.88% | 83.69% | -69.10% | -95.41% | 52.02% |
Vishnu Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 17% |
| 3 Years: | 11% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 42% |
| 3 Years: | 16% |
| TTM: | 25% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 75% |
| 3 Years: | 6% |
| 1 Year: | 19% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 22% |
| 3 Years: | 21% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 1:51 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 78 | 88 | 69 | 82 | 64 | 49 | 62 | 65 | 47 | 69 | 74 |
| Inventory Days | 230 | 314 | 269 | 212 | 201 | 252 | 243 | 143 | 142 | 263 | 242 |
| Days Payable | 117 | 225 | 201 | 207 | 147 | 167 | 174 | 146 | 120 | 187 | 172 |
| Cash Conversion Cycle | 191 | 176 | 137 | 87 | 117 | 134 | 131 | 63 | 69 | 145 | 145 |
| Working Capital Days | 37 | 3 | -70 | -24 | -3 | 2 | 6 | 10 | 21 | 54 | 67 |
| ROCE % | 21% | 14% | 16% | 17% | 14% | 12% | 24% | 30% | 20% | 18% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Bandhan Small Cap Fund | 652,741 | 0.6 | 23.26 | 652,741 | 2025-04-22 17:25:16 | 0% |
| ITI Small Cap Fund | 546,761 | 0.85 | 17.7 | 546,761 | 2025-04-22 17:25:16 | 0% |
| Bandhan Core Equity Fund | 434,782 | 0.44 | 15.5 | 434,782 | 2025-04-22 17:25:16 | 0% |
| ITI Pharma and Healthcare Fund | 63,910 | 1.37 | 2.07 | 63,910 | 2025-04-22 17:25:16 | 0% |
| ITI Value Fund | 47,008 | 0.87 | 1.52 | 47,008 | 2025-04-22 17:25:16 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 19.23 | 15.90 | 22.86 | 68.13 | 28.88 |
| Diluted EPS (Rs.) | 19.23 | 15.90 | 22.86 | 68.13 | 28.88 |
| Cash EPS (Rs.) | 24.48 | 20.55 | 27.29 | 87.37 | 45.87 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 137.67 | 107.00 | 69.37 | 231.77 | 164.19 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 137.67 | 107.00 | 69.37 | 231.77 | 164.19 |
| Revenue From Operations / Share (Rs.) | 214.89 | 185.05 | 232.88 | 894.86 | 568.12 |
| PBDIT / Share (Rs.) | 36.20 | 32.66 | 41.07 | 135.12 | 67.19 |
| PBIT / Share (Rs.) | 30.53 | 27.54 | 36.63 | 115.88 | 50.20 |
| PBT / Share (Rs.) | 24.99 | 21.94 | 31.05 | 94.03 | 28.46 |
| Net Profit / Share (Rs.) | 18.81 | 15.43 | 22.86 | 68.13 | 28.88 |
| NP After MI And SOA / Share (Rs.) | 18.81 | 15.43 | 22.86 | 68.13 | 28.88 |
| PBDIT Margin (%) | 16.84 | 17.64 | 17.63 | 15.09 | 11.82 |
| PBIT Margin (%) | 14.20 | 14.88 | 15.73 | 12.94 | 8.83 |
| PBT Margin (%) | 11.62 | 11.85 | 13.33 | 10.50 | 5.01 |
| Net Profit Margin (%) | 8.75 | 8.33 | 9.81 | 7.61 | 5.08 |
| NP After MI And SOA Margin (%) | 8.75 | 8.33 | 9.81 | 7.61 | 5.08 |
| Return on Networth / Equity (%) | 13.66 | 14.41 | 32.95 | 29.39 | 17.58 |
| Return on Capital Employeed (%) | 17.99 | 19.84 | 31.99 | 25.40 | 13.47 |
| Return On Assets (%) | 7.75 | 7.62 | 12.99 | 8.89 | 4.46 |
| Long Term Debt / Equity (X) | 0.17 | 0.11 | 0.34 | 0.46 | 0.50 |
| Total Debt / Equity (X) | 0.36 | 0.34 | 0.72 | 1.04 | 1.17 |
| Asset Turnover Ratio (%) | 0.97 | 1.02 | 1.40 | 1.18 | 0.78 |
| Current Ratio (X) | 1.70 | 1.58 | 1.28 | 1.13 | 1.06 |
| Quick Ratio (X) | 0.88 | 0.81 | 0.71 | 0.67 | 0.48 |
| Inventory Turnover Ratio (X) | 4.02 | 2.69 | 3.89 | 2.86 | 1.60 |
| Dividend Payout Ratio (NP) (%) | 1.55 | 2.59 | 1.74 | 1.46 | 3.46 |
| Dividend Payout Ratio (CP) (%) | 1.19 | 1.94 | 1.46 | 1.14 | 2.18 |
| Earning Retention Ratio (%) | 98.45 | 97.41 | 98.26 | 98.54 | 96.54 |
| Cash Earning Retention Ratio (%) | 98.81 | 98.06 | 98.54 | 98.86 | 97.82 |
| Interest Coverage Ratio (X) | 6.53 | 5.83 | 7.35 | 6.19 | 3.09 |
| Interest Coverage Ratio (Post Tax) (X) | 4.40 | 3.75 | 5.09 | 4.12 | 2.33 |
| Enterprise Value (Cr.) | 3341.23 | 2341.14 | 1974.14 | 2250.42 | 636.06 |
| EV / Net Operating Revenue (X) | 2.31 | 1.93 | 1.42 | 2.11 | 0.93 |
| EV / EBITDA (X) | 13.71 | 10.94 | 8.05 | 13.94 | 7.92 |
| MarketCap / Net Operating Revenue (X) | 2.13 | 1.72 | 1.16 | 1.78 | 0.50 |
| Retention Ratios (%) | 98.44 | 97.40 | 98.25 | 98.53 | 96.53 |
| Price / BV (X) | 3.32 | 2.98 | 3.90 | 6.87 | 1.74 |
| Price / Net Operating Revenue (X) | 2.13 | 1.72 | 1.16 | 1.78 | 0.50 |
| EarningsYield | 0.04 | 0.04 | 0.08 | 0.04 | 0.10 |
After reviewing the key financial ratios for Vishnu Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 19.23. This value is within the healthy range. It has increased from 15.90 (Mar 24) to 19.23, marking an increase of 3.33.
- For Diluted EPS (Rs.), as of Mar 25, the value is 19.23. This value is within the healthy range. It has increased from 15.90 (Mar 24) to 19.23, marking an increase of 3.33.
- For Cash EPS (Rs.), as of Mar 25, the value is 24.48. This value is within the healthy range. It has increased from 20.55 (Mar 24) to 24.48, marking an increase of 3.93.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 137.67. It has increased from 107.00 (Mar 24) to 137.67, marking an increase of 30.67.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 137.67. It has increased from 107.00 (Mar 24) to 137.67, marking an increase of 30.67.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 214.89. It has increased from 185.05 (Mar 24) to 214.89, marking an increase of 29.84.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 36.20. This value is within the healthy range. It has increased from 32.66 (Mar 24) to 36.20, marking an increase of 3.54.
- For PBIT / Share (Rs.), as of Mar 25, the value is 30.53. This value is within the healthy range. It has increased from 27.54 (Mar 24) to 30.53, marking an increase of 2.99.
- For PBT / Share (Rs.), as of Mar 25, the value is 24.99. This value is within the healthy range. It has increased from 21.94 (Mar 24) to 24.99, marking an increase of 3.05.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 18.81. This value is within the healthy range. It has increased from 15.43 (Mar 24) to 18.81, marking an increase of 3.38.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 18.81. This value is within the healthy range. It has increased from 15.43 (Mar 24) to 18.81, marking an increase of 3.38.
- For PBDIT Margin (%), as of Mar 25, the value is 16.84. This value is within the healthy range. It has decreased from 17.64 (Mar 24) to 16.84, marking a decrease of 0.80.
- For PBIT Margin (%), as of Mar 25, the value is 14.20. This value is within the healthy range. It has decreased from 14.88 (Mar 24) to 14.20, marking a decrease of 0.68.
- For PBT Margin (%), as of Mar 25, the value is 11.62. This value is within the healthy range. It has decreased from 11.85 (Mar 24) to 11.62, marking a decrease of 0.23.
- For Net Profit Margin (%), as of Mar 25, the value is 8.75. This value is within the healthy range. It has increased from 8.33 (Mar 24) to 8.75, marking an increase of 0.42.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.75. This value is within the healthy range. It has increased from 8.33 (Mar 24) to 8.75, marking an increase of 0.42.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.66. This value is below the healthy minimum of 15. It has decreased from 14.41 (Mar 24) to 13.66, marking a decrease of 0.75.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.99. This value is within the healthy range. It has decreased from 19.84 (Mar 24) to 17.99, marking a decrease of 1.85.
- For Return On Assets (%), as of Mar 25, the value is 7.75. This value is within the healthy range. It has increased from 7.62 (Mar 24) to 7.75, marking an increase of 0.13.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 0.2. It has increased from 0.11 (Mar 24) to 0.17, marking an increase of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.36. This value is within the healthy range. It has increased from 0.34 (Mar 24) to 0.36, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.97. It has decreased from 1.02 (Mar 24) to 0.97, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has increased from 1.58 (Mar 24) to 1.70, marking an increase of 0.12.
- For Quick Ratio (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has increased from 0.81 (Mar 24) to 0.88, marking an increase of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.02. This value is within the healthy range. It has increased from 2.69 (Mar 24) to 4.02, marking an increase of 1.33.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 1.55. This value is below the healthy minimum of 20. It has decreased from 2.59 (Mar 24) to 1.55, marking a decrease of 1.04.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 20. It has decreased from 1.94 (Mar 24) to 1.19, marking a decrease of 0.75.
- For Earning Retention Ratio (%), as of Mar 25, the value is 98.45. This value exceeds the healthy maximum of 70. It has increased from 97.41 (Mar 24) to 98.45, marking an increase of 1.04.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 98.81. This value exceeds the healthy maximum of 70. It has increased from 98.06 (Mar 24) to 98.81, marking an increase of 0.75.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.53. This value is within the healthy range. It has increased from 5.83 (Mar 24) to 6.53, marking an increase of 0.70.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.40. This value is within the healthy range. It has increased from 3.75 (Mar 24) to 4.40, marking an increase of 0.65.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,341.23. It has increased from 2,341.14 (Mar 24) to 3,341.23, marking an increase of 1,000.09.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.31. This value is within the healthy range. It has increased from 1.93 (Mar 24) to 2.31, marking an increase of 0.38.
- For EV / EBITDA (X), as of Mar 25, the value is 13.71. This value is within the healthy range. It has increased from 10.94 (Mar 24) to 13.71, marking an increase of 2.77.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.13. This value is within the healthy range. It has increased from 1.72 (Mar 24) to 2.13, marking an increase of 0.41.
- For Retention Ratios (%), as of Mar 25, the value is 98.44. This value exceeds the healthy maximum of 70. It has increased from 97.40 (Mar 24) to 98.44, marking an increase of 1.04.
- For Price / BV (X), as of Mar 25, the value is 3.32. This value exceeds the healthy maximum of 3. It has increased from 2.98 (Mar 24) to 3.32, marking an increase of 0.34.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.13. This value is within the healthy range. It has increased from 1.72 (Mar 24) to 2.13, marking an increase of 0.41.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vishnu Chemicals Ltd:
- Net Profit Margin: 8.75%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.99% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.66% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.4
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.88
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 26.5 (Industry average Stock P/E: 197.5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.36
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.75%
Fundamental Analysis of Vishnu Chemicals Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | Plot No. C-23, Road No. 8, Film Nagar, Jubilee Hills, Hyderabad Telangana 500096 | investors@vishnuchemicals.com http://www.vishnuchemicals.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Cherukuri Krishna Murthy | Chairman & Managing Director |
| Mr. Siddartha Cherukuri | Joint Managing Director |
| Mrs. Cherukuri Manjula | Non Executive Director |
| Mr. Tirthankar Mitra | Independent Director |
| Mr. Chetan Navinchandra Shah | Independent Director |
| Mr. Veeramachaneni Vimalanand | Independent Director |
| Dr. Sita Vanka | Independent Director |
Vishnu Chemicals Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹305.00 |
| Previous Day | ₹310.40 |